Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots (Q37167336)

5 February 2018

10 references

3 April 2019

25 June 2019

6 August 2019

19 September 2019

1 October 2019

10 August 2020

14 September 2020

4 November 2020

8 February 2021

22 August 2022

Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots (English)

1 reference

5 February 2018

pharmaceutical preparation

0 references

1 reference

3 April 2019

1 reference

PubMed

biomedical investigative technique

6 August 2019

1 reference

19 September 2019

1 reference

1 October 2019

1 reference

10 August 2020

1 reference

14 September 2020

1 reference

4 November 2020

1 reference

8 February 2021

1 reference

Todd Peterson

7

0 references

Marcel P Bruchez

object named as

Marcel P Bruchez

9

0 references

Hamid Daneshvar

1

object named as

Hamid Daneshvar

1 reference

5 February 2018

author name string

Jennifer Nelms

2

1 reference

5 February 2018

Osman Muhammad

3

1 reference

5 February 2018

Heather Jackson

4

1 reference

5 February 2018

Jean Tkach

5

1 reference

5 February 2018

William Davros

6

1 reference

5 February 2018

Michael A Vogelbaum

8

1 reference

5 February 2018

Steven A Toms

10

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 February 2008

1 reference

5 February 2018

published in

Nanomedicine

1 reference

5 February 2018

International Journal of Nanomedicine

11 references

3 April 2019

25 June 2019

6 August 2019

19 September 2019

1 October 2019

1 June 2020

10 August 2020

14 September 2020

4 November 2020

8 February 2021

22 August 2022

3

1 reference

5 February 2018

page(s)

21-29

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

Pros and cons of the liposome platform in cancer drug targeting

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Comparing antibody and small-molecule therapies for cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Medical application of functionalized magnetic nanoparticles

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Folate receptor-mediated drug targeting: from therapeutics to diagnostics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Liposomal encapsulated anti-cancer drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Future directions of liposome- and immunoliposome-based cancer therapeutics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Drug transport to brain with targeted liposomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Recent advances with liposomes as pharmaceutical carriers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Antibody pharmacokinetics and pharmacodynamics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Liposome-based approaches to overcome anticancer drug resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Folate receptor-targeted liposomes as vectors for therapeutic agents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Tumor targeting using anti-her2 immunoliposomes.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Campath-1H monoclonal antibody therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Current status of pH-sensitive liposomes in drug delivery

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Clinical trials of single-agent trastuzumab (Herceptin).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Noninvasive gene targeting to the brain

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Immunoliposomes for the targeted delivery of antitumor drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Immunotoxins for targeted cancer therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

An inventory of the human ABC proteins

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Brain drug delivery of small molecules using immunoliposomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Current status of the structural and functional basis of glomerular filtration and proteinuria.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Activation of Kupffer cell tumoricidal activity by immunomodulators encapsulated in liposomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Development of liposomal amphotericin B formulation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Polymer vesicles in vivo: correlations with PEG molecular weight.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Pharmacologic approaches to reversing multidrug resistance.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

A new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

The role of surface charge and hydrophilic groups on liposome clearance in vivo

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Noninvasive imaging of quantum dots in mice

27 June 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Semiconductor nanocrystals as fluorescent biological labels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Quantum dot bioconjugates for ultrasensitive nonisotopic detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Quantum dots for live cells, in vivo imaging, and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

In vivo molecular and cellular imaging with quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Quantum dots are powerful multipurpose vital labeling agents in zebrafish embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

In vivo optical imaging using quantum dots for the management of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

In vitro cytotoxicity of nanoparticles in mammalian germline stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

In vivo cancer targeting and imaging with semiconductor quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

In vivo brain tumor demarcation using optical spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Fluorescence spectroscopy of neoplastic and non-neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

In vivo optical spectroscopy detects radiation damage in brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Neuro-oncological applications of optical spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Water-soluble quantum dots for multiphoton fluorescence imaging in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Synthesis of water-dispersible fluorescent, radio-opaque, and paramagnetic CdS:Mn/ZnS quantum dots: a multifunctional probe for bioimaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Magnetic labeling of activated microglia in experimental gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Renal clearance of quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Intraoperative imaging in glioblastoma resection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Measurement of intraoperative brain surface deformation under a craniotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Correlation of intraoperative ultrasound tumor volumes and margins with preoperative computerized tomography scans. An intraoperative method to enhance tumor resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.3.1.21

In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Global non-viral gene transfer to the primate brain following intravenous administration.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

By-passing of P-glycoprotein using immunoliposomes

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Direct measurement of a tethered ligand-receptor interaction potential

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

Cationic liposome-mediated intravenous gene delivery

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526358

3 September 2018

Identifiers

DOI

10.2217/17435889.3.1.21

1 reference

5 February 2018

PMCID

2526358

1 reference

18 August 2017

1 reference

5 February 2018